Journal News

JBC: A phospholipid pathway from plants to parasites

Sasha Mushegian
June 1, 2018

Findings by researchers at Washington University in St. Louis may aid in the development of therapies to treat parasitic infections, including malaria, and may help plant scientists one day produce hardier crops. The research team’s work was published in the Journal of Biological Chemistry.

A study explains how structures of Arabidopsis phosphoethanolamine methyltransferase, or PMT, (left) are evolutionarily related to PMT sequences from different organisms. Phosphatidylcholine (right) is PMT's product. Courtesy of Soon Goo Lee and Joseph JezCholine is an essential nutrient that we get from certain foods, including eggs, meat, leafy greens and nuts. The human body converts choline into phosphocholine, or pCho, which it in turn converts into (among other essential building blocks) phosphatidylcholine, or PtdCho, a component of cell membranes. Plants can’t acquire the nutrient from the environment and so must synthesize pCho from scratch. The biochemical pathway plants use to synthesize pCho also is found in nematodes and the malaria parasite Plasmodium.

In plants, the enzymatic reaction that produces pCho is essential for normal function and for responding to stresses. Plant pCho is converted into PtdCho, which builds membranes that can adjust their rigidity in response to temperature changes. pCho also gets converted into molecules that help plants survive high salt. The enzymes that produce plant pCho are called phosphoethanolamine methyltransferases, or PMTs.

Soon Goo Lee, a postdoctoral research fellow at Washington University in the lab of Joseph Jez (a JBC associate editor), has been fascinated by PMTs in both plants and parasites for many years.

“Understanding the PMT enzyme is key to engineer plants with improved stress tolerance and enhanced nutrients,” Lee said.

Since the PMT-catalyzed pathway is found in parasites but not humans, Lee and Jez’s team is looking for inhibitors of this enzyme to treat diseases caused by these parasites.

The new study explains that PMTs of the model plant Arabidopsis thaliana share core features of PMTs from parasites, with almost identical structure at the active site. But the plant PMTs are roughly twice as large as the parasite ones, with large sections that can rearrange themselves to carry out multiple chemical reactions.

The three PMT types in the plant — which were thought to carry out the same function — actually appear to play different roles depending on where they are found in the plant. Plant growth experiments showed that one type of PMT was essential for root development and salt tolerance, whereas the other two had no effect on roots and instead seemed to be found primarily in leaves.

In the long run, this big-picture view of PMTs in different organisms offers routes to engineer enzymes with different functions. “I love these kinds of stories,” Lee said, “where I can look from the atomic (structure) to the physiological level to explain why these enzymes have different forms and how they work.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sasha Mushegian

Sasha Mushegian is a postdoctoral fellow at Georgetown University. Follow her on Twitter.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.